Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Ig-Innovations

Ig-Innovations Ltd is a brand new company with over 30 years experience in antibody production and immunoassay development. Confusing but true – the experience and expertise is in the people we employ not the name we give the company. Born-out of the acquisition of the diagnostics division of MicroPharm, Ig has captured the skills and expertise developed during the research and development of sheep derived polyclonal antibodies for human therapy (now FDA & MHRA licensed products), diagnostics and research.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Ig-Innovations
Gernos, Maesllyn, Llandysul, SA44 5LP
+44 (0)1239 858972
Contact Ig-Innovations
Website

 Latest Content from PMHub 

Rewarding Long Service at Bedrock

Press Releases | November 6, 2019 | Resonant Group

Katie Penfold celebrates 5 years with the Bedrock Group

Restoring Equilibrium at Lucid Group

Press Releases | November 6, 2019 | Lucid Group Communications Limited

It’s National Stress Awareness Day, which is a great opportunity to take a moment to think about our wellbeing. This time of year is often busier than normal. At Lucid,...

Lucid Group celebrates a fang-tastic Halloween

Press Releases | November 4, 2019 | Lucid Group Communications Limited

Last week the Lucid charity working group, Lucid SPIRIT, organised a fang-tastic Halloween Bingo evening to raise money for its charity partner, Wycombe Homeless Connection (WHC).Lucidians went to town with...

OPEN Health announces the integration of Pharmerit International into the group

Press Releases | November 4, 2019 | OPEN Health

OPEN Health has today announced the integration of Pharmerit International, a global leader in health economics and outcomes research (HEOR), into its group of companies.

Article: Market access in Brazil

White Papers and Resources | November 1, 2019 | Inizio

All eyes on Spinraza

China: How to strategise and win in the world’s fastest changing healthcare market

White Papers and Resources | November 1, 2019 | Inizio

In this paper, experts Marc Yates, Pei Li Teh and Brett Gardiner discuss the China healthcare reforms which affect pharma and propose how to build the market understanding required to launch...

Infographic: Preparing to launch a new asset and in need of demand assessment research?

White Papers and Resources | November 1, 2019 | Inizio

Download our pre-launch checklist

How ready are you for launch?

White Papers and Resources | November 1, 2019 | Blue Latitude Health

Pharmaceutical launches are becoming more complex and competitive. Our launch excellence diagnostic tool helps you to map how ready you are for launch, while facilitating success in this challenging environment.

Does your pre-launch strategy really drive behaviour change?

White Papers and Resources | October 31, 2019 | Blue Latitude Health

One of the most interesting parts of a pharmaceutical launch is delving into the minds of stakeholders to understand why they behave in the way that they do. Blue Latitude...

Digitalising healthcare: what can the NHS learn from other industries?

White Papers and Resources | October 31, 2019 | Blue Latitude Health

Expensive digital solutions are often disregarded because they do not work well for the end user. Account Manager Fiona Grace explores this challenge and reveals the stories of innovation we...